Growth & Weight Gain in ELBW Infants Fed an Exclusively Human Milk Based

Status Completed

Clinical Trial Summary

Preterm infants are susceptible to postnatal growth restriction. Breast milk is the recommended source of nutrition for preterm infants. As preterm infants have enhanced nutritional requirements, multicomponent fortifiers are added to breast milk in order to establish adequate growth.

Due to the various benefits of human milk feds to preterm infants, a human milk fortifier based on donor milk (Prolact+6 H2MF® Prolacta, City of Industry, California) has been developed. With this study, the investigators want to evaluate the effect of human milk fortification on weight gain in extremely low birth weight infants (ELBW, <1000g birth weight) in comparison to bovine fortification.

Clinical Trial Description

Preterm infants are susceptible to postnatal growth restriction. Breast milk is the recommended source of nutrition for preterm infants. Many positive short-term health effects like prevention necrotizing enterocolitis , effects on gut development and immunological issues are associated with breast milk feedings.

The composition of breast milk usually meets the nutritional demands of term infants. As preterm infants have enhanced nutritional requirements, multicomponent fortifiers are added to breast milk in order to establish adequate growth and proper neurodevelopmental outcome.

Due to the various benefits of human milk feds to preterm infants, a human milk fortifier based on donor milk (Prolact+6 H2MF® Prolacta, City of Industry, California) has been developed. This human milk fortifier contains more energy and protein than bovine milk fortifiers. So far, accurate data on growth and weight gain under an exclusive diet with human milk and the human milk fortifier Prolact+6H2MF®are missing. With this study, the investigators want to evaluate the impact of a human milk based fortifier on weight gain in extremely low birth weight infants (ELBW, <1000g birth weight) in comparison to bovine milk based fortifier. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03886844
Study type	Observational
Source	Medical University of Vienna
Contact
Status	Completed
Phase
Start date	December 2015
Completion date	November 2018

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT03249896` - Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes	N/A
Recruiting	`NCT04043520` - Bioenergetic Effects of Aging and Menopause (BEAM)	Phase 4
Completed	`NCT05508750` - Growth and Safety Clinical Trial on a New Infant Formula	N/A
Not yet recruiting	`NCT03225456` - Oxytocin and Eating	Phase 2
Completed	`NCT02227043` - Study Of Weight Development Over Time	N/A
Not yet recruiting	`NCT01916603` - Diet, Physical Activity and Breastfeeding Intervention on Maternal Nutrition, Offspring Growth and Development	N/A
Completed	`NCT01958307` - Healthy Living in Pregnancy	N/A
Completed	`NCT01693666` - Lifestyle Intervention Forever: Healthy Weight for Pregnancy and Birth (Pilot Study)	N/A
Completed	`NCT01461824` - Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects	Phase 3
Terminated	`NCT00759993` - Chromium Piccolinate in the Prevention of Weight Gain Induced by Serotonergic Medications Initiated on Psychiatric Inpatient Units.	Phase 2
Completed	`NCT00634530` - Impact of a Nutritional Intervention Program for Weight Control During Pregnancy	N/A
Completed	`NCT00995462` - Prevention of Weight Gain in University Students	N/A
Completed	`NCT00122213` - A Physical Activity and Diet Program to Prevent Accumulation of Abdominal Fat Mass in Recently Retired Men and Women	Phase 2
Completed	`NCT00306449` - Prevention of Weight Gain in Young Adults	N/A
Completed	`NCT03996551` - ExeRTiOn2- The Weight Gain Prevention Exercise in Renal Transplant Online Study	N/A
Recruiting	`NCT03675464` - Study of Human Adipose Tissue (LOSHAT)
Completed	`NCT04282655` - Effect of Milk Warming on the Very Low Birth Weight Infant	N/A
Recruiting	`NCT05992688` - The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)	N/A
Completed	`NCT04069351` - Body Composition Changes During Overfeeding Plus Resistance Training	N/A
Completed	`NCT00687115` - Predicting Weight Gain and Weight Loss Associated With Overeating or Fasting	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Growth and Weight Gain in ELBW Infants Fed an Exclusively Human Milk Based Diet With Prolacta®

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms